just watching and holding
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PUF Ventures Provides Update Regarding the Business of Natures Hemp Corp.
Canada NewsWire
VANCOUVER, July 18, 2018
VANCOUVER, July 18, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update on the business of its subsidiary Natures Hemp Corp. ("Natures Hemp").
PUF Ventures (CNW Group/PUF Ventures)
Natures Hemp, a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, and Cannvas MedTech Inc. ("Cannvas"), a leading business technology company within the cannabis space, are pleased to announce the signing of a letter of intent (the "LOI"), to negotiate in good faith a data analytics agreement, for which Cannvas will provide industry insight and analytical modelling capabilities to Natures Hemp business models and Key Performance Indicators (KPIs).
"As we work to complete the plan of arrangement with Natures Hemp, it continues to make strides to become a leading biotechnology and consumer products company," said Derek Ivany, President and CEO, of PUF Ventures. "It is currently working with the University of Manitoba to develop proprietary an organic hemp-based milk which contains no sugar and no cholesterol, is free of soy and gluten and is an abundant source of vital nutrients. The recent letter of intent between Natures Hemp and Cannvas could lead to an agreement and provide valuable market data and analytics to Natures Hemp as it looks to introduce new and exciting hemp-based products. I am very pleased that the two PUF spin-out companies are working together to create shareholder value."
Under the terms of the LOI, Cannvas will develop specific parameters within its existing Cannvas Data framework to collect data and analytics from Natures Hemp and their strategic partnerships, and Natures Hemp is expected to gain access to a broad data set as they press forward in the hemp sector and becomes a stand-alone public company. It is expected that the LOI and a subsequent agreement will allow Natures Hemp to bring the right products to market at the right time and to the right individuals, and will maximize Natures Hemp customer conversion funnel.
Cannvas Data is the analytics branch of Cannvas MedTech. Its mission is to collect data from various credible sources to enhance user personal data algorithms for Cannvas.me. Cannvas Data is expected to leverage existing databases, site traffic and advanced technology for marketing purposes, and is expected to leverage its comprehensive solution for the global hemp community. Cannvas and Natures Hemp have agreed to a discovery period whereby the technological specifications of the connectivity will be setup by Cannvas Data. Cannvas and Natures Hemp will work together towards a definitive partnership agreement within the next 45 days.
About Natures Hemp Corp.
Natures Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness. Currently. Natures Hemp is a subsidiary of PUF. Pursuant to the previously announced plan of arrangement between Natures Hemp and PUF, if the plan of arrangement is approved by the shareholders of PUF and the court, it is expected that Natures Hemp will become a reporting issuer.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany
President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
News Story
PUF Ventures Engages Cannabis Compliance Inc. for Large-scale Greenhouse Facility in Delta, BC
05 Jul 2018 08:30 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that it has engaged Cannabis Compliance Inc. (CCI) to prepare the new Propagation Canada Services (PSC) cannabis propagation facility in Delta, BC. CCI has more than 10 years experience providing risk mitigation, due diligence and regulatory compliance to commercial cannabis producers and resellers worldwide.
"We are very pleased to be working with the team at PUF, the Houwelings Group and the recently formed Propagation Services Canada, as they introduce large-scale propagation services to the cannabis sector," said Deepak Anand, Vice President of Business Development & Government Relations at Cannabis Compliance Inc. "This is one of the larger facilities that CCI has had the pleasure to work on and provide our regulatory expertise in preparation for Health Canada review. We have many clients who could benefit from this new propagation service to significantly increase revenue, protect intellectual property, reduce plant mortality and have a cleaner, safer and purer product for consumers."
"I believe that an independent propagation services in the Canadian cannabis space, will massively disrupt cannabis growing methods in a very positive way," said Derek Ivany, president and CEO of PUF Ventures. "Plant propagation is a scientific proposition requiring high tech labs and facilities, knowledgeable technicians and complex procedures to operate a successful operation. We are currently working with Casey to upgrade the existing greenhouses whereby PSC will supply flower-ready plants to growers and licensed producer and eliminate most of the technical risk of growing cannabis."
As previously announced Propagation Services Canada was recently formed by PUF Ventures and Casey Houweling, a vegetable greenhouse grower with over 40 years of propagation growing experience. Houweling currently operates a large-scale vegetable propagation business with greenhouse propagation operations in a 2.2 million square foot facility located in Delta, British Columbia. The facility is well suited to propagate flower-ready cannabis starter plants and will be the largest cannabis grower by number of plants in the world at a full capacity.
Propagation of cannabis plants is a highly technical and complicated process that can improve strain purity, eliminate contaminants and reduce diseases. By offering flower-ready plants to cannabis cultivators, growing operations are significantly simplified, the growing area allocated to harvest increased, resulting in meaningfully improved top line revenue and operating profits. PSC starter plants mitigate risk and allows cannabis cultivators to focus upon growing and processing flowering plants.
"The combination, of one of the most technically advanced greenhouse sites entering the cannabis industry and more than 40 years of propagation experience, is precisely what the cannabis industry requires to deliver clean, pure stock plants," said Nico Hache, Cultivation Consultant at Cannabis Compliance Inc. "The nursery plant mortality rate in the industry is very high due to lack of facility and technical expertise to grow at scale. PSC has a facility, the technical expertise and with a few modifications will change the way cannabis is grown. This expertise is what has been missing in the industry and will be welcomed by licensed producer."
About Cannabis Compliance Inc.
CCI, as one of Canada's original cannabis consulting firms, offers risk mitigation, due diligence, and regulatory licensing consulting services for commercial cannabis producers and resellers. CCI has extensive expertise in cultivation/horticulture, security designs/tender, facility designs/build-outs, quality assurance programs, and financial planning. CCI has strategic partnerships globally to secure investment partners for its clients, general contractors for buildouts, security tenders, equipment suppliers, media, government relations, and enterprise resource planning software. For over a decade, CCI's experienced team has been involved in commercial cannabis operations in Canada delivering proven results for their clients.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/July2018/05/c7419.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
PUF Ventures Inc. Signing of Arrangement Agreement
24 May 2018 16:05 ET
CNW Group
PUF Ventures Inc. Signing of Arrangement Agreement
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), announces that, further to its news release of April 4, 2018, it has entered into an arrangement agreement (the "Arrangement Agreement") dated May 18, 2018 with its subsidiary Natures Hemp Corp. ("Natures Hemp") whereby the Company will transfer the assets (the "Assets"), being the business of development of cannabidiol extraction from seeds and other plant parts for the creation of high quality oils and flours, proprietary hemp base food and medicinal products into Natures Hemp by way of a plan of arrangement (the "Arrangement") pursuant to Division 5 of Part 9 of the Business Corporations Act (British Columbia), and Natures Hemp will become a reporting issuer in the Provinces of British Columbia, Alberta and Ontario upon completion of the Arrangement.
The purpose of the Arrangement is to allow the Company to divest itself of the Assets to Natures Hemp, enabling the Company to focus on the cultivation and future sales of cannabis with both THC and CBD and other vertically integrated products concerning cannabis. Natures Hemp will have a diversified management team, with special focus on hemp-related products, isolate extractions and related nutraceutical and medicinal products.
The Arrangement will be subject to the approval of the Supreme Court of British Columbia, as well as approval by the PUF shareholders at a special meeting to be held on Tuesday, August 7, 2018 (the "Meeting"). Pursuant to the Arrangement, PUF will distribute 17,500,000 (100%) of the common shares of Natures Hemp (the "Natures Hemp Shares") it receives to the PUF shareholders on a pro rata basis. The PUF shareholders will be entitled to receive one Natures Hemp Share in exchange for approximately every four (4) common shares of PUF held as at June 18, 2018 (the "Record Date"). There will be no change in shareholders' holdings in PUF as a result of the Arrangement. No outstanding warrants or options of PUF will be transferred over to Natures Hemp.
Following completion of the Arrangement, (i) Natures Hemp will hold the Assets transferred to it by PUF, (ii) Natures Hemp will become a reporting issuer in the Provinces of British Columbia, Alberta and Ontario, intends to apply for listing on the Canadian Securities Exchange (the "Exchange"), and must meet the listing requirements of the Exchange. (iii) each PUF shareholder will continue to be a PUF shareholder, (iv) all the PUF shareholders will have become shareholders of Natures Hemp, and (v) PUF will retain its working capital for its Assets, and remain listed on the Canadian Securities Exchange and will continue to trade under the trading symbol, PUF, as a consumer products - biotechnology/pharmaceuticals company.
Details of the proposed Arrangement will be provided in a Management Information Circular that will be mailed to all the PUF shareholders as at the Record Date. At the Meeting, the PUF shareholders will be asked to vote on a special resolution approving the Arrangement. The PUF shareholders of record as at the Record Date will be eligible to vote on the Arrangement. The Arrangement will be posted on SEDAR under the profile of PUF.
The effective date of the Arrangement is expected to be in September 2018. A further press release will be issued by the Company with additional details regarding the Arrangement and when the exact effective date is known.
Additionally, Natures Hemp is in the process of raising funds by way of special warrant financings. It is expected that the special warrants will be converted into shares of Natures Hemp after the Meeting.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek Ivany President & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in PUF's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should, aware" and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements including statements related to PUF's transactions and business related to cannabis and future news releases.
Although PUF has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited operating history or when very limited due diligence was performed or may be engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. PUF disclaims any intention or obligation to update or revise such information, except as required by applicable law, and PUF does not assume any liability for disclosure relating to any other company mentioned herein.
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/24/c8107.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities
04 May 2018 08:30 ET
CNW Group
PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce the formation of a wholly owned subsidiary Pure Grow Medicinals S.A.S. in Colombia to pursue additional international opportunities in the cannabis industry.
"Colombia is in the early stages of legalizing cannabis for medicinal and export purposes, and represents a strategic opportunity for PUF" said Derek Ivany, President and CEO of the Company. "It is a cannabis friendly jurisdiction where we have established local business relationships. We are in discussions and conducting due diligence on several projects with significant potential. By leveraging our experience in other international markets, we will ensure the success of Pure Grow Medicinals."
Medical cannabis was formally legalized in Colombia in 2015. Like Canada, local producers must obtain licenses from the government for the cultivation of psychoactive and non-psychoactive plants. Due to its proximity to the equator, Colombia has the ideal natural environmental to grow many different crops including cannabis. Plants are grown in open-air greenhouses, under a 12-hour sun cycle, throughout the year, and there is ample access to natural water sources. A minimal requirement for electricity and access to water are substantial cost advantages making Colombia one of the lowest cost cannabis producers in the world.
Internationally, PUF Ventures currently owns a 35 percent stake in Solaris Nutraceuticals, a private company based in Australia which is building a 1.2 million sq. ft., hi-tech, ultra-efficient, large-scale cannabis greenhouse in New South Wales, Australia. A potential project in Colombia represents a second international project to be undertaken by PUF Ventures.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
News Story
PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
18 Apr 2018 08:30 ET
CNW Group
PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update regarding its spin out company Cannvas MedTech Inc.'s ("MTEC" or the "Cannvas") Plan of Arrangement which closed on January 16, 2018.
The shareholders of PUF as at the record date of October 4, 2017 were eligible to receive one MTEC share for every seven shares of PUF held. The Plan of Arrangement closed on January 16, 2018, and the MTEC shares were distributed in anticipation to a listing on the Canadian Stock Exchange (the "CSE"). The Cannvas executive team has been working closely with the CSE and is in the final stages of listing.
"The pending listing on the CSE for the spinout of our non-core asset Vapetronix, which is now Cannvas, is another prime example of how to create value for our shareholders," said Derek Ivany, President and CEO of PUF. "I believe Cannvas is on its way to become a leading health sciences company within the cannabis space. I congratulate Shawn Moniz and Steve Loutskou for their hard work and dedication with Cannvas, and I look forward to the company's public listing to unlock real value to PUF shareholders."
In the first quarter of 2018, the executive team at Cannvas made considerable progress to position the company as a leading business technology company within the health sciences industry. Cannvas designs and builds customer-centric technology platforms that enable partners to harness the power of data to truly understand their customers. Their first product to be launched in 2018 is a dynamic educational platform for the cannabis space. Here are additional milestones achieved by the Cannvas team:
-- In the final stages of listing on the CSE;
-- Setup several complimentary online brands: Cannvas Creative,
Cannvas Data, Cannvas Connect, and techonesixty,
-- Cannvas Creative, a marketing and branding agency which offers
services to clients to achieve growth that outperforms the
market, has been generating revenue since January 2018,
-- Secured various digital assets including several hundred
domains,
-- Initiated discussions with several leading organizations within
the health sciences and technology sectors to establish
partnerships,
-- Participating in several medical advisory and health innovation
boards.
Shawn Moniz, CEO of Cannvas, and Steve Loutskou, Chief Operation Officer, Global Markets, continue to work diligently with various government agencies working toward the listing on the CSE and other partnerships and networking advancements within the health sciences sector.
On April 4, 2018, PUF announced a second spin-out of non-core assets for its wholly owned subsidiary Natures Hemp Corp. ("Natures Hemp"). Like the Cannvas transaction, the Natures Hemp transaction will be completed by way of a Plan of Arrangement and a listing application to the CSE. Natures Hemp is a biotechnology and consumer products company that is unlocking the true value of hemp. By developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products, its goal is to introduce a premium brand of quality CBD products with an emphasis on health and wellness. The Plan of Arrangement will have to be approved by the shareholders of the Company and the Supreme Court of British Columbia.
About Cannvas MedTech Inc.
Cannvas Medtech is a leading business technology company within the health sciences space. We design and build customer- centric platforms that enable our partners to harness the power of data to truly understand their customers.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/April2018/18/c6248.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
MYM Nutraceuticals Inc., (CSE: MYM.CN) (MYM.CN) in response to an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant and its strategic partners PUF Ventures Inc. (CSE: PUF) are pleased to announce the Australia based Solaris Nutraceuticals Pty Ltd, which is building the largest medical cannabis greenhouse southern hemisphere, has been awarded a $AUD2,500,000 Regional Jobs Investment Program (RJIP) grant, through Federal Department of Innovation, Industry & Science.
"We are co-investing with Solaris Nutraceuticals to make sure it (the medicinal cannabis facility) happens," said Kevin Hogan, Australian Member of Parliament. "Up to 280 jobs will be there one day providing this great new product that is needed by our community. We look forward to having the largest medicinal cannabis facility in the Southern Hemisphere soon in Casino."
"We are very honoured to be awarded this Federal Grant towards the construction of our 1,200,000 sq. f.t greenhouse," said Michael Horsfall, Co-founder and CEO of Solaris Nutraceuticals. "We have been overwhelmed with the generous support we have received from all levels of Government. We are working hard to deliver this project. We expect to create upwards of 300 to 500 direct and indirect jobs in the Northern Rivers Region from our greenhouse project. This will provide a significant boost to the local economy."
The new facility will be Australia's largest growing, manufacturing, processing and research facility in Australia. This is an innovative project which will help patients, create new jobs, complete further research and develop new products in the medical cannabis field.
The company is currently in the assessment stage for three licenses with the Office of Drug Control in Canberra.
Kevin Hogan, Member of Parliament: https://m.facebook.com/story.php?story_fbid=1694316460660111&id=356113427813761&refsrc=http%3A%2F%2Ft.co%2F4LMgCG1HkD&_rdr
"Getting financial support from the local government at this scale is unprecedented," said Rob Gietl, CEO of MYM. "We are very excited about the Northern rivers project and the economic impact it can have for the area and Solaris Nutraceuticals Inc."
The project is scheduled to break ground this Summer with phase one completed by the end of 2018. Project completion is scheduled for Q4 2019.
About Solaris Nutraceuticals (MYM owns 35%)
Solaris Nutraceuticals is an innovative medical technology company with headquarters in Sydney, Australia. It has proposed plans and applications with Office of Drug Control in Australia to build a 1.2 Million square foot glass house with a medical research center and manufacturing facility in the Northern Rivers Region of New South Wales Australia. Our corporate mission is to deliver an environmentally friendly, sun grown medicinal grade cannabis and on developing medicines and treatments for pain management along with a number of other medical conditions and specific plant based nutraceuticals. Our focus is on innovations that promote, support and deliver improvements in the quality, consistency and cost of medicines to our clients.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
Here's to our Future Growth and Prosperity Together.
ON BEHALF OF THE BOARD
Rob Gietl, CEOMYM Nutraceuticals Inc.http://www.mymarijuana.ca
Keep up to date with MYM on our social media channels:
Twitter: @MYM_Nutra
Facebook: @mymcanada
Instagram: @MYM_Nutra
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com .
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
SOURCE MYM Nutraceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/February2018/15/c7740.html
SOURCE: MYM Nutraceuticals Inc.
Investor Relations, Terry Brown, +1-855-696-2261, terry@mymarijuana.ca
Copyright (C) 2018 CNW Group. All rights reserved.
Chart not available
Important Legal Notice: All market
Cannvas Medtech Inc. Forms Technology Partnership with Blox Labs for Digital Marketing and Branding
01 Feb 2018 08:30 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), and Cannvas Medtech Inc. ("MTEC") are pleased to announce the formation of a technology partnership between MTEC and Blox Labs Inc. (CSE: BLOX) (US OTC: BLLXF) (FSE: BR1B), a technology company specialized in decentralized ledger technology, smart contracts and blockchain development.
MTEC will use its extensive expertise in strategic creative marketing campaigns including SEO, digital branding and other related services to create a high-quality strategic communications campaign for Blox's investor base and partners as the it drives its business growth with multiple blockchain projects. The increased connectivity will facilitate the sharing of Blox news, projects and media through digital and mobile networks. This alliance also opens the door to exploring new and innovative digital business solutions.
"I would like to congratulate Shawn and Steve of MTEC upon their first contract after the January 16, 2018 completion of the plan of arrangement between PUF Ventures and Cannvas Medtech," said Derek Ivany, President and CEO of PUF Ventures. "This contract is the first of many and represents a significant milestone as the MTEC team works toward their upcoming listing on the Canadian Stock Exchange. It was a very successful for all at the 2018 Cantech Investor Conference held in Toronto yesterday."
"The Cannvas team is truly excited about our new partnership with BLOX. We have a dynamic team, we understand the marketplace, and we know that our experience designing strategic creative campaigns on a global scale will form the basis of a successful and enduring partnership," said Steve Loutskou, CSO at MTEC. "Our work is founded on strategic thinking and creative differentiation, with the addition of in-depth analytics which allows us to not only deliver effective campaigns but also provide significant and real return on investment for our partners."
Cannvas MedTech believes in the power of data to help build customer-centric initiatives in the medical technology sector. Millions of ideas are created every day, a fraction of those address an actual business need, and fewer still have the business plan to disrupt the status quo in becoming game changers in today's ever-changing markets. At Cannvas MedTech Inc. we focus our efforts towards data-driven business solutions that put the end user in the driver seat. From access to investors, target customers and industry-leading experts, our company enables other companies to scale and succeed as global industry leaders. For more information visit: www.cannvasmedtech.com.
About PUF Ventures Inc.
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
Derek IvanyPresident & CEO
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
SOURCE PUF Ventures
View original content with multimedia: http://www.newswire.ca/en/releases/archive/February2018/01/c2526.html
SOURCE: PUF Ventures
PUF Ventures Inc., E: ir@puf.ca, T: (800) 783-6056
Copyright (C) 2018 CNW Group. All rights reserved.
does anybody know where this stock(business) is headed for.thanks
More than 1,000 Hollywood Movies, Top IMAX Documentaries, Award Winning TV Series and Concerts and Beautiful Moving Art now available for Roku 4 customers
NanoTech Entertainment (OTCPINK: NTEK), a pioneer in bringing the most visually stunning streaming TV experience to consumers, announced today that UltraFlix is now available for the Roku® 4 streaming player. UltraFlix features a vast library of beautiful 4K content, giving Roku 4 owners even more options for finding 4K-quality video to stream whenever they want.
Nanotech has been building its’ 4K library for nearly two years to deliver an extensive collection of 4K entertainment. With a combination of native 4K digital titles, 4K film scanning, high-quality scaling techniques and a dedicated team of video artists, UltraFlix has successfully amassed a selection of Hollywood hits from major studios such as Paramount, MGM, Millennium, Magnolia and Warner, award-winning documentaries made for IMAX theatres, hot new TV series from A&E Networks and stunning time-lapse motion art from top independent producers from around the globe.
Roku customers in the U.S. who own a Roku 4 streaming player can use the UltraFlix channel to view 4K-quality TV shows and movies such as The Terminator, Star Trek, Mission Impossible, The Godfather, Transformers, GI Joe, Gladiator, World War Z, IMAX thrillers and many more all-time Hollywood classics.
“The success of the Roku platform and its strong customer engagement can be attributed to the company’s focus on choice, a simple user experience and innovation,” said Aaron Taylor, NanoTech's Executive Vice President of Sales & Marketing. “That focus aligns with NanoTech’s mission to deliver the most visually stunning movies, music, documentaries and award-winning television series for our customers. We’re delighted to bring UltraFlix and its library of on-demand 4K entertainment to the Roku 4 streaming player, and are confident Roku customers will enjoy the quality and selection of content within the UltraFlix channel.”
Roku 4 customers can find the UltraFlix channel within the 4K Ultra HD category in the Roku Channel Store.
About UltraFlix
Offering the world’s largest library of 4K Ultra HD content, UltraFlix is a streaming network that enables users to choose from a library of pristine 4K Ultra HD VOD content in a broad range of categories which include hours of free content. UltraFlix has also become the preferred 4K set-top box and Smart TV App for leading 4K Smart TV manufacturers including Samsung, Sony, Vizio, HiSense and others that are in the process of completing their testing and integration. www.UltraFlix.com.
About NanoTech Entertainment
Headquartered in San Jose, CA, the heart of Silicon Valley, NanoTech Entertainment is a technology company that focuses on 4K media procurement, production, processing and delivery. NanoTech’s solutions includes the world's first 4K Ultra HD streaming service which is now found on most major 4K TV and OTT Streaming Devices. Nanotech’s 4K Studios creates digital 4K Ultra HD content using both licensed materials as well as original productions. www.NTEK.com.
"Safe Harbor" Statement: This press release contains forward-looking statements, including expected industry patterns and other financial and business results that involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: the sustainability of recent growth rates in of the company; the positioning of NanoTech Entertainment, Inc. in the market; ability to integrate both developed and acquired companies and technology; ability to retain key employees; ability to successfully market product offerings and customer acceptance of products; general market conditions, fluctuations in currency exchange rates, changes to systems and product strategy by vendors of systems; and whether NanoTech Entertainment, Inc. can successfully gain market share. Actual results may differ materially from those contained in the forward-looking statements in this press release. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151204005543/en/
NanoTech Entertainment
Marketing Contact:
Aaron Taylor, 408-414-7355 x134
aaron@ntek.com
or
Investor Contact:
Dan Wong, 858-381-4622
dwong@ntek.com
Copyright Business Wire 2015
niko,
what is the ticker sign for vizio?
thanks
what is the ticker for vizio?
I was paid a divy as well, but, we were supposed to receive quarterly divys.
what is the ticker sign for Samsung.
thanks
any news yet!!!
thanks.
News will come!!! so will Christmas.(sarcasm)
i agree totally. thanks
us markets closed @ noon on Thursday july 03/2014.
I called and they said they distribute 1 product.
we need a positive pr today. thnks
I sure hope something comes out. Something positive hopefully.
children will play!!!!
what news
merry Christmas everyone and all the best in 2014.
merry Christmas everyone and all the best in 2014.
one sick puppy!!!!LOL
does anybody have an opinion
i thought we would have more news by now.
anybody have news on this stock
any news coming. anybody!!!
what is going on with ials
wow!!! WHAT!!!!!
how much further
check this out:This Week on MoneyTV with Donald Baillargeon, 10/11
11 Oct 2013 05:23 ET
ACCESSWIRE
Los Angeles, CA / ACCESSWIRE / History of repealing bad laws, mining, cloud computing, bioplastics, mobile payments, mortgage rates; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net/), featuring informative interviews with company CEOs, providing insights into their operations and outlooks for their futures.
Free information packages from the featured companies can be requested by sending an email to info@moneytv.net.
The television program can also be viewed online immediately at http://www.moneytv.net/.
Featured companies on this week's program include:
DNA Precious metals, Inc. (OTCBB: DNAP) CEO Ronald Mann discussed the company's mining properties and their close proximity to well known producing properties. MoneyTV has initiated coverage.
Axiologix, Inc. (AXLX) CEO Vincent Browne discussed the company's cloud computing services business model. MoneyTV has initiated coverage.
Cereplast, Inc (OTCBB: CERP) CEO Frederic Scheer announced two major developments for the company in both Italy and India.
Singlepoint, Inc. (SING) CEO Greg Lambrecht talked about growth by both acquisition and organically.
The Mortgage Minute Guy Roger Schlesinger discussed low mortgage rates and the threat they may soon increase.
A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net/ MoneyTV Executive Producer and Anchor Donald Baillargeon is also the host of MoneyRap Radio, http://www.moneyrap.com/ and the daily television program Global Financial News Minute with Donald Baillargeon.
MoneyTV with Donald Baillargeon television program, Copyright MMXIII, all rights reserved. MoneyTV does not provide an analysis of companies' financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,995.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by Donald Baillargeon, the producer, publisher or parent company of MoneyTV.
Source: MoneyTV
http://www.accesswire.com/img.ashx?id=408603
Copyright 2013 ACCESSWIRE
Chart not available
Important Legal Notice: All market data is provided by a third party vendor and is delayed by at least 20 minutes unless otherwise noted. BMO InvestorLine is not responsible for the information provided and disclaims all liability for such quotes. For further information, please refer to o
Kenactiv Innovations Inc. Announces East Coast Distribution Agreement with Monroe Hardware Company, Inc. for its Organic Plant Health Line of Lawn and Garden Care Products
CHARLOTTE, N.C., Feb. 11, 2013 /PRNewswire/ -- Kenactiv Innovations Inc. (OTCQB: OPHID) ("Kenactiv") a manufacturer of sustainable bio-based products and solutions for industry, business and consumers has announced a distribution agreement for its Organic Plant Health (OPH) line of professional grade lawn and garden care products with Monroe Hardware Company, Inc. headquartered in Monroe, NC. The agreement expands distribution of the OPH brand of organic-based and hybrid fertilizers and soil conditioners along the East Coast and coincides with the launch of new branding and packaging for OPH.
(Photo: http://photos.prnewswire.com/prnh/20130211/NY58083)
(Logo: http://photos.prnewswire.com/prnh/20130125/NY48332LOGO)
"This partnership with OPH and Kenactiv is a great opportunity for Monroe Hardware to bring value to our 2500 independent retailers and help them stay at the forefront of the lawn and garden market," said Keith Driscoll, Director of Purchasing, for Monroe Hardware. "We launched the line at our Spring Dealers' Market, and there was tremendous excitement surrounding OPH. It's a very timely addition to our offerings—retailers tell us consumers are looking for a path to great lawns and gardens, but are increasingly concerned with conventional products and the chemicals they contain. OPH offers proven results with less watering, less chemicals, and a great user experience."
Billy Styles, OPH division president, introduced the line at the Monroe event. "Independent retailers, such as Monroe's customers, are our ideal partners. They really get behind the OPH brand because they live in the communities they serve and know their customers are looking to change the way they grow things. Organic Plant Health products support soil health and provide long-term results and true plant health, without toxic chemicals that impact our communities and the planet."
The Organic Plant Health line offers complete solutions for residential and commercial turf and garden care. Twenty-three products are grouped to target the specific needs of soil, lawns, garden and flower, and tree and shrub health, as well as pest and disease control. They work to restore the natural balance of soil and strengthen plants' ability to access nutrients and hydration for better health and natural resilience to stress such as disease and pests. New packaging focuses on guiding the consumer to the right solution at the right time for their specific need. Detailed product use information supports desired outcomes and increases consumer confidence.
Organic Plant Health products will be available this spring through Monroe Hardware Company Inc. hardware and lawn and garden partners in Georgia, South Carolina, North Carolina, Tennessee, Kentucky, West Virginia, Virginia, Maryland and Delaware.
About Kenactiv Innovations Inc.
In addition to the Organic Plant Health brand, Kenactiv produces natural fiber based products used in packaging, textiles, automotive parts, oil drilling, plastic composites, agriculture and environmental management. By replacing petroleum based products and other, less sustainable, natural products with Kenactiv's line of products derived from kenaf, manufacturers can greatly reduce their carbon footprint, reduce costs and improve the performance of their products.
Kenaf is a rapidly renewable crop with an extremely favorable environmental footprint and applications in a broad range of industries. Kenactiv's innovative processes and technologies activate the tremendous power of kenaf to make many of the products the world relies on better while also reducing the environmental impact of manufacturing, distributing and disposing of them. The Company, headquartered in Scottsdale (AZ), was founded in 2008 in Snow Hill (NC) where it owns and operates a 160,000 square foot manufacturing facility.
About Monroe Hardware Distribution Company
Monroe Hardware has been successful since 1886 by continuing its original business principle of guaranteeing customer satisfaction. William Henry Belk, one of the founders of Monroe Hardware Company, was also the founder of the Belk department store chain that is now the largest group of family and management-owned department stores in the U.S. When he opened his first store in Monroe, NC, in 1888, Belk bought large quantities of goods, sold them at low mark-ups, and guaranteed customer satisfaction. His innovative ideas are still the primary business model at Belk and Monroe Hardware Company. Monroe Hardware serves 2500 hardware and garden center stores in the Southeast.
CONTACT:
MARGARET SKRILOFF
KENACTIV INNOVATIONS, INC.
7077 EAST MARILYN ROAD, STE 140
SCOTTSDALE, AZ 85254
Office: (480) 779-0046 EXT. 507
Toll free: (888) 999-6772 EXT. 507
Fax: (480) 779-0177
email: ir@kenactiv.com
website: www.kenactiv.com
SOURCE Kenactiv Innovations Inc.
i need the price to be over $1.265 to be even.
i got my shares on the jan 30th.
what about this .02 ex.dividend